Hypofractionated Radiation Acceptable for Localized Prostate Cancer
|
By MedImaging International staff writers Posted on 05 Nov 2018 |
|
A new study supports the use of shortened courses of radiation therapy (RT) for early-stage prostate cancer (PC).
Researchers at the University of Ottawa (Canada), Cedars-Sinai Medical Center (Los Angeles, CA, USA), Vanderbilt University Medical Center (VUMC; Nashville, TN, USA), and other institutions participating in a new task force convened by the American Society for Radiation Oncology (ASTRO) conducted a systematic literature review to address key questions and develop an evidence-based guideline for dose-fractionation RT for early-stage PC.
Among the issues discussed were technical aspects, including normal tissue dose constraints, treatment volumes, and use of image guided RT (IMRT) and intensity modulated RT (IMRT). Based on high-quality evidence, a strong consensus was reached to offer moderate hypofractionation across risk groups to patients choosing external beam RT (EBRT), and recommended ultrahypofractionated RT for low- and intermediate-risk PC. For high-risk patients, the routine use of ultrahypofractionated EBRT was not recommended. The study was published on October 11, 2018, in Practical Radiation Oncology.
“These recommendations are intended to provide guidance on moderate hypofractionation and ultrahypofractionation for localized prostate cancer. Men who opt to receive hypofractionated radiation therapy will be able to receive a shorter course of treatment,” concluded lead author Scott Morgan, MD, of the University of Ottawa, and colleagues. “The limits in the current evidentiary base, especially for ultrahypofractionation, highlight the imperative to support large-scale randomized clinical trials and underscore the importance of shared decision making between clinicians and patients.”
RT fractionation is defined as a fraction size of 180 to 200 cGy. Hypofractionation is subdivided into moderate hypofractionation (240-340 cGy) and ultrahypofractionation (a fraction size higher 500 cGy). These pragmatic definitions reflect two distinct approaches to hypofractionation that have emerged in clinical practice. The fraction size gap created (i.e., the gap from 340 cGy and 500 cGy) represents a little-studied range.
Related Links:
University of Ottawa
Cedars-Sinai Medical Center
Vanderbilt University Medical Center
Researchers at the University of Ottawa (Canada), Cedars-Sinai Medical Center (Los Angeles, CA, USA), Vanderbilt University Medical Center (VUMC; Nashville, TN, USA), and other institutions participating in a new task force convened by the American Society for Radiation Oncology (ASTRO) conducted a systematic literature review to address key questions and develop an evidence-based guideline for dose-fractionation RT for early-stage PC.
Among the issues discussed were technical aspects, including normal tissue dose constraints, treatment volumes, and use of image guided RT (IMRT) and intensity modulated RT (IMRT). Based on high-quality evidence, a strong consensus was reached to offer moderate hypofractionation across risk groups to patients choosing external beam RT (EBRT), and recommended ultrahypofractionated RT for low- and intermediate-risk PC. For high-risk patients, the routine use of ultrahypofractionated EBRT was not recommended. The study was published on October 11, 2018, in Practical Radiation Oncology.
“These recommendations are intended to provide guidance on moderate hypofractionation and ultrahypofractionation for localized prostate cancer. Men who opt to receive hypofractionated radiation therapy will be able to receive a shorter course of treatment,” concluded lead author Scott Morgan, MD, of the University of Ottawa, and colleagues. “The limits in the current evidentiary base, especially for ultrahypofractionation, highlight the imperative to support large-scale randomized clinical trials and underscore the importance of shared decision making between clinicians and patients.”
RT fractionation is defined as a fraction size of 180 to 200 cGy. Hypofractionation is subdivided into moderate hypofractionation (240-340 cGy) and ultrahypofractionation (a fraction size higher 500 cGy). These pragmatic definitions reflect two distinct approaches to hypofractionation that have emerged in clinical practice. The fraction size gap created (i.e., the gap from 340 cGy and 500 cGy) represents a little-studied range.
Related Links:
University of Ottawa
Cedars-Sinai Medical Center
Vanderbilt University Medical Center
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
PACS Workstation
CHILI Web Viewer
New
Compact C-Arm
Arcovis DRF-C S21
New
Ultrasound Table
Ergonomic Advantage (EA) Line
Latest Nuclear Medicine News
- New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment
- Low-Dose Radiation Therapy Demonstrates Potential for Treatment of Heart Failure
Channels
Radiography
view channel
Novel Breast Imaging System Proves As Effective As Mammography
Breast cancer remains the most frequently diagnosed cancer among women. It is projected that one in eight women will be diagnosed with breast cancer during her lifetime, and one in 42 women who turn 50... Read more
AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
Radiologists typically detect one case of cancer for every 200 mammograms reviewed. However, these evaluations often result in false positives, leading to unnecessary patient recalls for additional testing,... Read more
MRI
view channel
Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
Magnetic Resonance Imaging (MRI) has significantly transformed healthcare, providing a noninvasive, radiation-free method for detailed imaging. It is especially promising for the future of medical diagnosis... Read more
World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
The world's first whole-body ultra-high field (UHF) MRI has officially come to market, marking a remarkable advancement in diagnostic radiology. United Imaging (Shanghai, China) has secured clearance from the U.... Read more
Ultrasound
view channel
Super-Resolution Imaging Technique Could Improve Evaluation of Cardiac Conditions
The heart depends on efficient blood circulation to pump blood throughout the body, delivering oxygen to tissues and removing carbon dioxide and waste. Yet, when heart vessels are damaged, it can disrupt... Read more
First AI-Powered POC Ultrasound Diagnostic Solution Helps Prioritize Cases Based On Severity
Ultrasound scans are essential for identifying and diagnosing various medical conditions, but often, patients must wait weeks or months for results due to a shortage of qualified medical professionals... Read more
Largest Model Trained On Echocardiography Images Assesses Heart Structure and Function
Foundation models represent an exciting frontier in generative artificial intelligence (AI), yet many lack the specialized medical data needed to make them applicable in healthcare settings.... Read more.jpg "Image: The Sonic Lumen Tomography (SLT) intravascular ultrasound system has received FDA 510(k) clearance (Photo courtesy of Provisio Medical)")
Groundbreaking Technology Enables Precise, Automatic Measurement of Peripheral Blood Vessels
The current standard of care of using angiographic information is often inadequate for accurately assessing vessel size in the estimated 20 million people in the U.S. who suffer from peripheral vascular disease.... Read moreGeneral/Advanced Imaging
view channel
Radiation Therapy Computed Tomography Solution Boosts Imaging Accuracy
One of the most significant challenges in oncology care is disease complexity in terms of the variety of cancer types and the individualized presentation of each patient. This complexity necessitates a... Read more
PET Scans Reveal Hidden Inflammation in Multiple Sclerosis Patients
A key challenge for clinicians treating patients with multiple sclerosis (MS) is that after a certain amount of time, they continue to worsen even though their MRIs show no change. A new study has now... Read more
Imaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Industry News
view channel
Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
Hologic, Inc. (Marlborough, MA, USA) has entered into a definitive agreement to acquire Endomagnetics Ltd. (Cambridge, UK), a privately held developer of breast cancer surgery technologies, for approximately... Read more
Bayer and Google Partner on New AI Product for Radiologists
Medical imaging data comprises around 90% of all healthcare data, and it is a highly complex and rich clinical data modality and serves as a vital tool for diagnosing patients. Each year, billions of medical... Read more
